Tonix Pharma (TNXP) Tops Q1 EPS by 284c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of $2.84. Revenue for the quarter came in at $2.43 million versus the consensus estimate of $4.2 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'
• INVO Fertility (IVF) Tops Q2 EPS by 105c